Are you interested in Sync? Submit your contact info here or click the "Contact me about Sync" button below and we will reach out to you with more information.
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.
Health News is provided as a service to Southpointe Pharmacy site users by HealthDay. Southpointe Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.